Krakow, 26 August 2014 – Selvita will participate and present at the upcoming Drug Discovery USA Congress, which will be held on 21 – 22 October 2014, in Boston, USA.
Ms Andrea Gerken, MBA, Deputy Director Alliance Manager at H3 BiomedicineSelvita’s together with Pawel Przewiezlikowski, Selvita’s Chief Executive Officer, will deliver a presentation speaking on the “Co-discovery Collaboration Between H3 Biomedicine And Selvita To Deliver Precision Medicine Clinical Candidates“.
Presentation will take place on October 21, at 09:30 during the “R&D for the Future” track.
The Drug Discovery USA Congress brings together a host of senior level experts to discuss recent developments in the industry and debate the best strategies and solutions to improve drug discovery going forward. The show offers over 40 presentations and case studies focused on the key issues in drug discovery and medicinal chemistry, within the following Interactive Streams:
- R&D Models For The Future
- Screening & Assays: Enabling Technologies
- Discovery Chemistry & Drug Design
- Supporting Innovation: Translational Approaches & Informatics Tools,
as well as pre-scheduled one to one meetings, exhibition and variety of informal networking opportunities.
To contact Selvita’s delegates at this conference please contact us at: +48 12 297 47 00 or [email protected]